Which of the following statements reflect current stem cell
research?
a) The stem cell is known as a precursor cell that continually
replenishes the body’s entire supply of both red and white cells.
The stem cell is known as a precursor cell that continually replenishes
the body’s entire supply of both red and white cells. Stem cells
comprise only a small portion of all types of bone marrow cells.
b) Stem cell transplantation can restore immune system functioning.
Research conducted with mouse models has demonstrated that once
the immune system has been destroyed experimentally, it can be
completely restored with the implantation of just a few purified stem
cells.
c) Stem cell transplantion has been performed in the laboratory only.
Stem cell transplantation has been carried out in human subjects with
certain types of immune dysfunction such as severe combined
immunodeficiency (SCID).
d) Clinical trials are underway in patients with acquired immune
deficiencies only.
Clinical trails are underway in patients with a variety of disorders with
an autoimmune component including systemic lupus erythematosus,
rheumatoid arthritis, scleroderma, and multiple sclerosis.
research?
a) The stem cell is known as a precursor cell that continually
replenishes the body’s entire supply of both red and white cells.
The stem cell is known as a precursor cell that continually replenishes
the body’s entire supply of both red and white cells. Stem cells
comprise only a small portion of all types of bone marrow cells.
b) Stem cell transplantation can restore immune system functioning.
Research conducted with mouse models has demonstrated that once
the immune system has been destroyed experimentally, it can be
completely restored with the implantation of just a few purified stem
cells.
c) Stem cell transplantion has been performed in the laboratory only.
Stem cell transplantation has been carried out in human subjects with
certain types of immune dysfunction such as severe combined
immunodeficiency (SCID).
d) Clinical trials are underway in patients with acquired immune
deficiencies only.
Clinical trails are underway in patients with a variety of disorders with
an autoimmune component including systemic lupus erythematosus,
rheumatoid arthritis, scleroderma, and multiple sclerosis.